Colorectal Cancer

Trials are underway for individuals with colorectal cancer. For a more comprehensive list of Nexavar® (sorafenib) clinical trials, please visit clinicaltrials.gov or call 866-639-2827.

Phase 2 Study of Nexavar in Combination with Modified FOLFOX6 - RESPECT
Enrollment Complete
Study Design: Randomized, double-blind, placebo-controlled trial
Patients: Stage IV patients with metastatic colorectal cancer
Purpose: To determine the effectiveness of Nexavar plus mFOLFOX6 chemotherapy when compared to mFOLFOX6 chemotherapy treatment alone by assessing the difference in progression-free survival (PFS), as well as to evaluate other measures of efficacy and safety
Location: Multiple centers throughout  Europe and Russia and one center in the United States

Stock Quote (update every 15 minutes): As of 4:00pm - 5/20/2011

  • Symbol
    ONXX
  • Last
    43.71 +0.22
  • Open
    43.46
  • High
    43.81
  • Low
    42.49
  • Volume
    1139204